Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01954173
What this trial is testing

Adjuvant Radiation for High Risk Bladder Cancer

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the BladderStage III Bladder Cancer+2 more
Emory University 19
Not applicableUnknownNCT06091683
What this trial is testing

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Not applicableEnded earlyNCT00925405
What this trial is testing

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05843253
What this trial is testing

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more
Nationwide Children's Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Large-scale testing (Phase 3)Active Not RecruitingNCT01349881
What this trial is testing

S0820, Adenoma and Second Primary Prevention Trial

Who this might be right for
Colorectal Neoplasms
SWOG Cancer Research Network 354
Testing effectiveness (Phase 2)Study completedNCT02050919
What this trial is testing

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Who this might be right for
Pleomorphic RhabdomyosarcomaStage IIB Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7+1 more
OHSU Knight Cancer Institute 20
Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Not applicableUnknownNCT02585219
What this trial is testing

Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas

Who this might be right for
Glioblastoma
University Medical Center Groningen 10
Not applicableNot Yet RecruitingNCT06954753
What this trial is testing

Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence

Who this might be right for
Pancreatic CancerPancreatic Cystic Lesions
Centre Hospitalier Universitaire de Nice 250
Testing effectiveness (Phase 2)Ended earlyNCT00462865
What this trial is testing

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Who this might be right for
Breast Cancer
Brown University 18
Not applicableStudy completedNCT01983267
What this trial is testing

Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.

Who this might be right for
1- Cancer Patients During Chemotherapy Treatment2- Use of Cannabis Comparing to Control Without Cannabis Use
Rambam Health Care Campus 100
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053
What this trial is testing

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis

Who this might be right for
Cirrhosis
VA Office of Research and Development 142
Not applicableStudy completedNCT01590472
What this trial is testing

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma

Who this might be right for
Mesothelioma
Wake Forest University 69
Not applicableLooking for participantsNCT06524167
What this trial is testing

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT00509353
What this trial is testing

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 26
Testing effectiveness (Phase 2)WithdrawnNCT00881595
What this trial is testing

Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcomas
University of Florida
Early research (Phase 1)Looking for participantsNCT06044857
What this trial is testing

PSMA PET Response Guided SabR in High Risk Pca

Who this might be right for
Prostate Adenocarcinoma
University of Texas Southwestern Medical Center 20
Next Page